Sec Form 3 Filing - Dorn Jessy Dana @ SECOND SIGHT MEDICAL PRODUCTS INC - 2019-09-25

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Dorn Jessy Dana 2. Issuer Name and Ticker or Trading Symbol SECOND SIGHT MEDICAL PRODUCTS INC [ EYES] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) VP-Clin & Scientific Affairs (Last) (First) (Middle) 12744 SAN FERNANDO ROAD, SUITE 400 3. Date of Earliest Transaction (MM/DD/YY) 09/25/2019 (Street) SYLMAR, CA91342 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 1,458 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Non-Qualified Stock Option(right to buy) $ 5 02/01/2011( 1 ) 02/01/2020 Common Stock 405 D Non-Qualified Stock Option(right to buy) $ 5 06/01/2011( 1 ) 06/01/2020 Common Stock 1,000 D Non-Qualified Stock Option(right to buy) $ 5 04/01/2015( 1 ) 04/01/2024 Common Stock 5,250 D Non-Qualified Stock Option(right to buy) $ 13.09 03/25/2016( 1 ) 03/25/2025 Common Stock 3,750 D Non-Qualified Stock Option(right to buy) $ 12.46 05/15/2016( 2 ) 05/15/2025 Common Stock 20,000 D Non-Qualified Stock Option(right to buy) $ 4.18 01/14/2017( 2 ) 01/14/2026 Common Stock 15,000 D Non-Qualified Stock Option(right to buy) $ 4.1 01/21/2017( 2 ) 01/21/2026 Common Stock 9,210 D Non-Qualified Stock Option(right to buy) $ 1.73 01/18/2018( 2 ) 01/18/2027 Common Stock 20,000 D Non-Qualified Stock Option(right to buy) $ 2.01 01/02/2019( 2 ) 01/02/2028 Common Stock 20,000 D Non-Qualified Stock Option(right to buy) $ 0.815 02/23/2019( 3 ) 01/23/2029 Common Stock 32,800 D Non-Qualified Stock Option(right to buy) $ 0.7088 07/04/2019( 3 ) 06/04/2029 Common Stock 75,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Dorn Jessy Dana 12744 SAN FERNANDO ROAD SUITE 400 SYLMAR, CA91342 VP-Clin & Scientific Affairs Signatures /s/ John T. Blake, Attorney-in-fact 10/02/2019 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The stock options have a 10-year term and vest over five years from the grant date in equal annual installments, subject to continuous employment, such that the total number shall be fully vested on the five-year anniversary of the transaction date. ( 2 )The stock options have a 10-year term and vest 25% on the first anniversary and then in equal quarterly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date. ( 3 )The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.